Morning Market Movers

Peregrine Pharmaceuticals

surged 39.26% to $1.88 at 9:45 am. Peregrine Pharmaceuticals provided an update from its internal review of discrepancies from its Phase II second-line non-small cell lung cancer (NSCLC) in 121 patients. Dialogic

shares advanced 31.34% to $2.39. Dialogic shares have dropped 54.50% over the past 52 weeks, while the S&P 500 index has gained 14.51% in the same period. Epocrates

surged 21.63% to $11.70. Epocrates agreed to be bought by athenahealth

for $11.75 per share in cash. RF Industries

climbed 19.56% to $5.3682. For the fourth quarter, RF Industries' preliminary unaudited revenue surged 77% y/y.